Isis Pharmaceuticals, Inc. (ISIS) Tops Q4 EPS by 20c

February 28, 2013 8:38 AM EST Send to a Friend
Get Alerts ISIS Hot Sheet
Trade ISIS Now!
Join SI Premium – FREE
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) reported Q4 EPS of ($0.03), $0.20 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $19.9 million versus the consensus estimate of $15.78 million.

For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment